BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castelo A, Mello CEB, Teixeira R, Madruga JVR, Reuter T, Pereira LMMB, Silva GF, Álvares-DA-Silva MR, Zambrini H, Ferreira PRA. HEPATITIS C IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM: BURDEN OF DISEASE. Arq Gastroenterol 2018;55:329-37. [PMID: 30785514 DOI: 10.1590/S0004-2803.201800000-74] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Spaderna M, Kattakuzhy S, Kang SJ, George N, Bijole P, Ebah E, Eyasu R, Ogbumbadiugha O, Silk R, Gannon C, Davis A, Cover A, Gayle B, Narayanan S, Pao M, Kottilil S, Rosenthal E. Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use. Int J Drug Policy 2023;111:103906. [PMID: 36384062 DOI: 10.1016/j.drugpo.2022.103906] [Reference Citation Analysis]
2 Estefan S, Brandão-Melo CE, Dos Santos Silva CM, Gomes DCK, Cardoso P, Costa MHS. Metabolic Evaluation in Patients With Hepatitis C Treated With Direct Antiviral Agents. Front Med (Lausanne) 2021;8:631600. [PMID: 34136497 DOI: 10.3389/fmed.2021.631600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Vivaldini SM, Ribeiro RA, Mosimann Júnior G, Tonini KC, Pereira GFM, Araújo WN. A real-life study of the positive response to DAA-based therapies for hepatitis C in Brazil. Braz J Infect Dis 2021;25:101573. [PMID: 33836175 DOI: 10.1016/j.bjid.2021.101573] [Reference Citation Analysis]
4 Ma J, He L, Chen K, Wang Y, Ren Y, Xing W, Jiang Y. Comparative study on anti-HCV testing using plasma, dried plasma spots (DPS), and dried blood spots (DBS). Biosafety and Health 2021;3:50-5. [DOI: 10.1016/j.bsheal.2020.06.003] [Reference Citation Analysis]
5 Vivaldini SM, Abraão Ribeiro R, Júnior GM, Tonini KC, Pereira GFM, de Araújo WN. A Real-life Study of the Positive Response to DAA-based Therapies for Hepatitis C in Brazil.. [DOI: 10.1101/2020.10.06.20207274] [Reference Citation Analysis]
6 Mattingly TJ 2nd, Love BL, Khokhar B. Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review. Pharmacoeconomics 2020;38:927-39. [PMID: 32533524 DOI: 10.1007/s40273-020-00933-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]